Cleroux J, Peterson M, Leenen F H
Br J Clin Pharmacol. 1987 Aug;24(2):225-9. doi: 10.1111/j.1365-2125.1987.tb03166.x.
Four groups of eight normotensive male volunteers performed a 60 min bicycle exercise test before and after 2 weeks of either placebo, hydrochlorothiazide (HCTZ, 25 mg day-1), pindolol (PIND, 10 mg day-1) or both drugs in combination using a double-blind, randomized design. During exercise on placebo serum potassium increased by 0.8 mmol l-1. HCTZ significantly decreased potassium levels at rest and during exercise by 0.2 mmol l-1. PIND did not affect resting potassium levels but potentiated the increase by 0.4 mmol l-1 at the end of exercise, and delayed the return to normal of serum potassium after exercise. The addition of HCTZ to PIND offset the potentiating effect of PIND on exercise-induced hyperkalaemia (only after prolonged exercise) and accelerated the return to baseline after exercise. The results indicate that the hypokalaemic effect of HCTZ can oppose the hyperkalaemic effect of PIND during prolonged physical exercise and particularly during recovery.
四组每组八名血压正常的男性志愿者采用双盲随机设计,在服用安慰剂、氢氯噻嗪(HCTZ,25毫克/天)、吲哚洛尔(PIND,10毫克/天)或两种药物联合使用两周前后,进行了60分钟的自行车运动测试。在服用安慰剂进行运动期间,血清钾升高了0.8毫摩尔/升。HCTZ使静息和运动期间的钾水平显著降低0.2毫摩尔/升。PIND不影响静息钾水平,但在运动结束时使钾升高增强0.4毫摩尔/升,并延迟运动后血清钾恢复正常。在PIND中加入HCTZ可抵消PIND对运动诱导的高钾血症的增强作用(仅在长时间运动后),并加速运动后恢复到基线水平。结果表明,在长时间体育锻炼期间,尤其是恢复期间,HCTZ的低钾血症作用可对抗PIND的高钾血症作用。